ALL DIGITAL, Dec 17, 2020/ iMediSync, a biotech startup developing an AI-driven early detection and therapeutic platform for optimal brain health. iMediSync will showcase a series of EEG analysis solution for brain mapping, launching its first brain mapping and therapeutic device: combining both EEG brain mapping and LED therapy.
Consumer Electronics Show(CES) is the world's largest annual trade show and used to be held early January in Las Vegas. Due to COVID-19, the Consumer Technology Association (CTA) announced CES 2021 is all-digital. The show opens from January 11th through 14th.
iMediSync has developed a dry sensing EEG brain mapping device with LED photo-biomodulators, iSyncWave. It will work together with iSyncMe – mobile application. Through the app, users will be able to access its cloud-based EEG analysis platform (iSyncBrain®), where the AI analyzes for any abnormalities in the brain function. The 19-channels of LED built-in iSyncWave provides photobiomodulation(PBM) as a non-pharmacological option. The dry sensors make the EEG brain mapping easier and PBM enables a comprehensive therapy at the time of measuring.
Last year at CES 2020, iMediSync drew great attention with their aMCI-amnestic mild cognitive impairment-screening solution, iSyncBrain MCI Classifier for early detection of dementia. At coming CES 2021, iMedisync will build global partnerships with medical device distribution companies, and pharmaceutical or digital therapeutics companies for verification of treatment effect.
During CES 2021, iMediSync will unveil their first EEG brain mapping and therapeutic device, iSyncWave along with iSyncMe. The two will work together not only in hospitals and clinics, but also in the public sector. They will allow for virtual quality care for those suffering from dementia and other neurological diseases. Visit www.imedisync.com for more information.
About CES
CES® is the most influential tech event in the world —proving the ground for breakthrough technologies and global innovators. This is where the world's biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA)®, CES features every aspect of the tech sector.
About iSyncWave
iSyncWave provides AI-driven cloud based EEG(electroencephalogram) brain mapping and personalized LED therapeutics. Especially, iSyncWave is a dry sensing device without using any gel/liquid as conventional EEG device. Conventional EEG devices mostly use gel/liquid to get proper signals from the brain, the most sensitive electrical signals from human body. To maximize the quality of signal, iSyncWave has its motor sensor built in to automatically adjust to people’s head-shape. Not only measuring the signal, iSyncWave provides personalized LED therapeutics which is called photo-biomodulation(PBM). As it can also be paired with iSyncMe – mobile app, it will add a feature to connect patients and doctors virtually in the near future.
About iMediSync
iMediSync (www.imedisync.com) has developed an AI-driven early detection and therapeutic platform for optimal brain health. iMediSync launched its first solution to detect Mild Cognitive Impairment (early stage of Alzheimer’s Disease) based on its proprietary EEG database in Korea last August 2020 (iSyncBrain MCI Classifier – KFDA Cleared). They conducted the clinical trial with multicenter hospitals with the result of 90%+ accuracy for its solution. The vision of iMediSync, just like iSyncBrain MCI Classifier, is to develop early detecting biomarkers for challenging neurological disorders and diseases, such as COMA, Parkinson’s, ADHD, Depression and etc.
iMediSync CES 2021 Full Exhibitor Media Kit: https://ces.vporoom.com/iMediSync